We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACGN
4151
DELISTED
Aceragen Inc
ACGN
$14K ﹤0.01%
+1,855
New +$15.8K
NH
4152
DELISTED
NantHealth, Inc
NH
$14K ﹤0.01%
+2,300
New +$21.5K
UPC icon
4153
Universe Pharmaceuticals Inc
UPC
$2.05M
$13K ﹤0.01%
6
+2
+50% +$7.65K
NCEL
4154
NewcelX Ltd
NCEL
$18.8M
$12K ﹤0.01%
50
-4
-7% -$1.25K
TRX icon
4155
TRX Gold Corp
TRX
$254M
$12K ﹤0.01%
33,300
-577,700
-95% -$190K
ARDS
4156
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$12K ﹤0.01%
+10,804
New +$13.4K
THMO
4157
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$11K ﹤0.01%
+853
New +$16.8K
EXN
4158
DELISTED
Excellon Resources Inc.
EXN
$11K ﹤0.01%
23,800
+7,300
+44% +$4.59K
QH
4159
Quhuo Limited Class A Ordinary Shares
QH
$15.5K
$10K ﹤0.01%
28
+8
+40% +$3.28K
CNTN
4160
Canton Strategic Holdings
CNTN
$149M
$9K ﹤0.01%
+30
New +$12.1K
UNCY icon
4161
Unicycive Therapeutics
UNCY
$137M
$9K ﹤0.01%
+1,100
New +$10.5K
NYMX
4162
DELISTED
Nymox Pharmaceutical Corp
NYMX
$9K ﹤0.01%
+19,742
New +$18.2K
IMV
4163
DELISTED
IMV Inc. Common Shares
IMV
$9K ﹤0.01%
+1,310
New +$13.6K
CIH
4164
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$9K ﹤0.01%
12,700
+1,900
+18% +$1.65K
NAVB
4165
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$9K ﹤0.01%
+12,633
New +$10.7K
TCBP
4166
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
0
GDC icon
4167
GD Culture Group
GDC
$6.99M
$7K ﹤0.01%
+2
New +$10.7K
MTC icon
4168
MMTec
MTC
$404M
$6K ﹤0.01%
268
-1,009
-79% -$37.2K
SMFL
4169
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$6K ﹤0.01%
+3
New +$6.62K
PIXY
4170
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
0
TMBR
4171
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$5K ﹤0.01%
316
-17,109
-98% -$249K
MITO
4172
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$4K ﹤0.01%
14,769
-32,008
-68% -$11K
ALNA
4173
DELISTED
Allena Pharmaceuticals
ALNA
$3K ﹤0.01%
+17,200
New +$2.66K
AAON icon
4174
Aaon
AAON
$7.3B
-145,586
Closed -$5.41M
AAP icon
4175
Advance Auto Parts
AAP
$3.35B
-13,500
Closed -$2.79M

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.